Elvia Cowan - 26 Feb 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: SVP, Finance & CAO
Signature: Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol: PCVX
Transactions as of: 26 Feb 2026
Net transactions value: +$164,732
Form type: 4
Filing time: 02 Mar 2026, 20:08:35 UTC
Previous filing: 29 Dec 2025
Next filing: 11 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cowan Elvia	SVP, Finance & CAO	C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS	Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact	02 Mar 2026	0001960048

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+10,681	+79%	$0.000000	24,215	26 Feb 2026	Direct	F1
transaction	PCVX	Common Stock	Options Exercise	$199,999	+7,716	+32%	$25.92	31,931	26 Feb 2026	Direct
transaction	PCVX	Common Stock	Tax liability	$15,061	-243	-0.76%	$61.98	31,688	28 Feb 2026	Direct	F2
transaction	PCVX	Common Stock	Tax liability	$20,205	-326	-1%	$61.98	31,362	02 Mar 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+17,855		$0.000000	17,855	26 Feb 2026	Common Stock	17,855	$60.00	Direct	F3
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-7,716	-7.3%	$0.000000	98,568	26 Feb 2026	Common Stock	7,716	$25.92	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
F2	Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F3	1/48 of shares subject to the option vest on March 26, 2026, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
F4	1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.